Considering that differences were observed only between the HER2+ BC and BBD spectra, by means of the ROC curve analysis, we searched for a cutoff point so that it is possible to discriminate serum samples from individuals with HER2+ BC with high accuracy. The gene discussed is ERBB2; the disease is breast cancer.